Shares of ValiRx plc (LON:VAL – Get Free Report) rose 13.5% during mid-day trading on Wednesday . The company traded as high as GBX 0.88 ($0.01) and last traded at GBX 0.88 ($0.01). Approximately 8,830,195 shares changed hands during mid-day trading, a decline of 62% from the average daily volume of 23,453,170 shares. The stock had previously closed at GBX 0.78 ($0.01).
ValiRx Stock Up 2.4 %
The company has a 50 day moving average of GBX 1.04 and a 200-day moving average of GBX 1.68. The company has a debt-to-equity ratio of 0.49, a current ratio of 6.65 and a quick ratio of 1.27. The company has a market cap of £1.08 million, a P/E ratio of -40.95 and a beta of 0.59.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Stories
- Five stocks we like better than ValiRx
- How to Invest in Biotech Stocks
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
